EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study

Lu Yang, Yuhang Liu, Yu Deng, Xiaoling Peng, Qiao Hu, Li Jiang, Yue Hu iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.14917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Lu Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Minist…. Hauptthemen laut MEDLINE: Lacosamide, Anticonvulsants, Seizures. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the efficacy, safety, and tolerability of adjunctive lacosamide therapy against focal seizures in young children (1 month – 4 years).

Methods

This non‐randomized, open‐label, and self‐controlled real‐world study included 105 children (1 month–4 years) with focal seizures treated with adjunctive lacosamide therapy at Children's Hospital of Chongqing Medical University.

Results

(1) The 50% response rates at 3, 6, 9, and 12 months of follow‐up were 58.1%, 61.0%, 57.1%, and 56.2%, while the seizure‐free rates were 27.6%, 34.3%, 32.4%, and 37.1%, respectively. The 50% response rate of the first addition of lacosamide for focal seizures was much higher than the second and later added treatment at 3 months ( p = 0.038). After 1 year of follow‐up, these children showed an improvement in neurodevelopmental levels ( p < 0.05). (2) Lacosamide retention rate was 72.7% (64/88) after 1 year of follow‐up. Lack of efficacy and serious adverse events were independent risk factors for the lacosamide retention rate. (3) During adjunctive lacosamide therapy, 13 (12.4%) patients reported adverse events and five (4.7%) patients withdrew due to adverse events, including vomiting drowsiness, ataxia (0.94%), neck itching with eczema (0.94%), irritability (1.88%), and gastrointestinal discomfort (0.94%).

Conclusion

Adjunctive lacosamide therapy was effective, safe, and well‐tolerated in young Chinese children with focal seizures in this study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LacosamideAnticonvulsantsSeizuresHumansMaleFemaleInfantChild, PreschoolTreatment OutcomeFollow-Up StudiesDrug Therapy, CombinationEpilepsies, Partial

Stichwörter der Autor:innen

adjunctive therapychildrenfocal seizureslacosamide

Substanzen

LacosamideAnticonvulsants

Autor:innen und Institutionen

  • Department of Neurology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chi…
  • Guangdong Provincial Key Laboratory of Interdisciplinary Research and Application for Data Science, BNU-HKBU United International College, Zhuhai, China.

ORCID-Profile: Yue Hu

Zitieren

APA

Yang, L., Liu, Y., Deng, Y., Peng, X., Hu, Q., Jiang, L., & Hu, Y. (2024). Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14917

Vancouver

Yang L, Liu Y, Deng Y, Peng X, Hu Q, Jiang L, et al. Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14917

BibTeX
@article{Yang2024,
  author = {Yang, Lu and Liu, Yuhang and Deng, Yu and Peng, Xiaoling and Hu, Qiao and Jiang, Li and Hu, Yue},
  title = {Efficacy, safety, and tolerability of adjunctive Lacosamide therapy for focal seizures in young children aged ≥1 month to ≤4 years: A real‐world study},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.14917}
}
Kostenlos starten →